NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Organigram Global Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Organigram Global Inc stock.
Undervalued: intrinsic value $2.79 per share, market price $0.93, margin of safety 66.7% (as of 2026-10-30).
A 1.7x revenue multiple, discounted for its losses, values the shares at $2.79; the price of $0.93 is 67% below that value.
Leak Score: 77/100 on 8 of 12 signals (Clear Leak).
All 84 Drug Manufacturers - Specialty & Generic stocks
OGI is undervalued (as of the 2026-10-30 close). A 1.7x revenue multiple, discounted for its losses, values the shares at $2.79; the price of $0.93 is 67% below that value.
$2.79 per share (as of the 2026-10-30 close), against a market price of $0.93. That is a margin of safety of 66.7%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
77 out of 100, which we rate "Clear Leak", on 8 of 12 value investing signals.